Suchergebnisse - "Yamaguchi, Kyoko"

PubPharm (5)

1

Inhibition of insulin-like growth factor-1 receptor enhances eribulin-induced DNA damage in colorectal cancer

enthalten in: Cancer science | 2022

von Yoshihiro, T. | Ariyama, H. | Yamaguchi, K. | +7

2

Characterization of the activity of the PI3K/mTOR inhibitor XL765 (SAR245409) in tumor models with diverse genetic alterations affecting the PI3K pathway

enthalten in: Molecular cancer therapeutics | 2014

von Yu, P. | Laird, A. | Du, X. | +22

3

Discovery of a novel class of highly potent, selective, ATP-competitive, and orally bioavailable inhibitors of the mammalian target of rapamycin (mTOR)

enthalten in: Journal of medicinal chemistry | 2013

von Takeuchi, C. | Kim, B. | Blazey, C. | +26

4

Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth

enthalten in: Molecular cancer therapeutics | 2011

von Yakes, F. | Chen, J. | Tan, J. | +15

5

Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases

enthalten in: Cancer research | 2009

von Qian, F. | Engst, S. | Yamaguchi, K. | +15

1
[1]